Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations
dc.contributor.author | Mikas, Sello Given | |
dc.contributor.author | Isaacs, Darren | |
dc.contributor.author | Chitongo, Rumbidzai | |
dc.date.accessioned | 2021-10-08T11:53:24Z | |
dc.date.available | 2021-10-08T11:53:24Z | |
dc.date.issued | 2021 | |
dc.description.abstract | The Integrase (IN) strand transfer inhibitor (INSTI), Dolutegravir (DTG), has been given the green light to form part of first-line combination antiretroviral therapy (cART) by the World Health Organization (WHO). DTG containing regimens have shown a high genetic barrier against HIV-1 isolates carrying specific resistance mutations when compared with other class of regimens.We evaluated the HIV-1 CRF02_AG IN gene sequences from Cameroon for the presence of resistanceassociated mutations (RAMs) against INSTIs and naturally occurring polymorphisms (NOPs), using study sequences (n = 20) and (n = 287) sequences data derived from HIV Los Alamos National Laboratory database. The possible impact of NOPs on protein structure caused by HIV-1 CRF02_AG variations was addressed within the context of a 3D model of the HIV-1 IN complex and interaction analysis was performed using PyMol to validate DTG binding to the Wild type and seven mutant structures. | en_US |
dc.identifier.citation | Mikasi, S. G. et al. (2021). Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations. BMC Infectious Diseases, 21(1),379. https://doi.org/10.1186/s12879-021-06059-x | en_US |
dc.identifier.issn | 1471-2334 | |
dc.identifier.uri | https://doi.org/10.1186/s12879-021-06059-x | |
dc.identifier.uri | http://hdl.handle.net/10566/6881 | |
dc.language.iso | en | en_US |
dc.publisher | BMC | en_US |
dc.subject | Cameroon | en_US |
dc.subject | Molecular modelling | en_US |
dc.subject | Dolutegravir drug | en_US |
dc.subject | World Health Organization (WHO) | en_US |
dc.subject | HIV-1 | en_US |
dc.title | Interaction analysis of statistically enriched mutations identified in Cameroon recombinant subtype CRF02_AG that can influence the development of Dolutegravir drug resistance mutations | en_US |
dc.type | Article | en_US |